Activation of common signaling pathways during remodeling of the heart and the bladder

Ivonne Koeck1, Fiona C Burkhard2, Katia Monastyrskaya3

  • 1Urology Research Laboratory, Department Clinical Research, University of Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, Switzerland.

Biochemical Pharmacology
|September 23, 2015
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in pressure overload injury affecting the heart and bladder. Understanding their role in organ remodeling offers new therapeutic targets for cardiac and bladder failure.

Area of Science:

  • Cardiovascular Biology
  • Urology
  • Molecular Biology

Background:

  • The heart and urinary bladder are susceptible to pressure overload injury from conditions like hypertension and bladder outlet obstruction.
  • This injury leads to organ hypertrophy, altered phenotype and function, and potentially acute organ failure due to fibrosis and loss of contractility.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in the pathogenesis of heart failure and bladder dysfunction.

Purpose of the Study:

  • To review current knowledge on molecular alterations in the heart and bladder under pressure overload.
  • To highlight common signaling pathways and regulatory events involving miRNAs in these organs.
  • To explore the therapeutic potential of targeting miRNAs for organ hypertrophy and failure.

Main Methods:

  • Literature review of studies on molecular alterations in cardiac and bladder hypertrophy.
  • Analysis of miRNA expression patterns and experimental validation of miRNA targets.
  • Identification of common signaling pathways in fibrotic remodeling of the heart and bladder.

Main Results:

  • Emerging evidence implicates miRNAs in the pathogenesis of heart failure and bladder dysfunction.
  • miRNAs regulate gene expression, controlling adaptive and maladaptive organ remodeling processes.
  • miRNA expression analysis in the heart provides insights for bladder and other organ research.
  • Aberrantly expressed miRNAs present opportunities for pharmacological intervention.

Conclusions:

  • miRNAs are crucial in the molecular mechanisms underlying cardiac and bladder hypertrophy and failure.
  • Shared signaling pathways and regulatory events exist between the heart and bladder in response to pressure overload.
  • Targeting miRNAs offers a promising therapeutic strategy for treating cardiac and bladder diseases characterized by hypertrophy and fibrosis.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
69.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.9K
Parasympathetic Signaling01:30

Parasympathetic Signaling

Parasympathetic signaling plays a crucial role in regulating various physiological processes. It involves the release of acetylcholine (ACh) by parasympathetic neurons, which can have localized and short-lived effects. The majority of ACh released is rapidly inactivated at the synapse by the enzyme acetylcholinesterase (AChE), which hydrolyzes Ach into choline and acetate. Additionally, the tissue cholinesterase deactivates any ACh diffusing into the surrounding tissues.
The effects of...
4.1K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K